Background: Primary endocrine therapy (PET) is a recognised alternative to surgery followed by endocrine therapy for a subset of older, frailer women with breast cancer. Choice of treatment is preference-sensitive and may require decision support. Older patients are often conceptualised as passive decision-makers. The present study used the Coping in Deliberation (CODE) framework to gain insight into decision making and coping processes in a group of older women who have faced breast cancer treatment decisions, and to inform the development of a decision support intervention (DSI). Methods: Semi-structured interviews were carried out with older women who had been offered a choice of PET or surgery from five UK hospital clinics. Women's ...
Kate J Lifford,1 Adrian Edwards,1 Maria Burton,2 Helena Harder,3 Fiona Armitage,4 Jenna L Morgan,4 L...
BACKGROUND: Decisions about adjuvant chemotherapy in older women with early stage breast cancer (EBC...
BackgroundRates of surgery and adjuvant therapy for breast cancer vary widely between breast units. ...
Background: Primary endocrine therapy (PET) is a recognised alternative to surgery followed by endoc...
Background: Primary endocrine therapy (PET) is a recognised alternative to surgery followed by endoc...
Objective Primary Endocrine Therapy (PET) is a good alternative to surgery for breast cancer in olde...
Objective Primary Endocrine Therapy (PET) is a good alternative to surgery for breast cancer in old...
Objective: Primary endocrine therapy (PET) is an alternative to surgery for oestrogen receptor pos...
Purpose: Primary endocrine therapy (PET) is the treatment of primary, operable breast cancer with d...
Objectives: To establish older women's (≥75 years) information preferences regarding two breast canc...
Objectives: To establish older women's (≥75 years) information preferences regarding two breast canc...
Background: Around one-third of breast cancers diagnosed every year in the UK are in women aged ≥70 ...
Primary endocrine therapy (PET) as an alternative to surgery is widely used in the UK for the treatm...
Objective Primary endocrine therapy (PET) is an alternative to surgery for oestrogen receptor posit...
Kate J Lifford,1 Adrian Edwards,1 Maria Burton,2 Helena Harder,3 Fiona Armitage,4 Jenna L Morgan,4 L...
BACKGROUND: Decisions about adjuvant chemotherapy in older women with early stage breast cancer (EBC...
BackgroundRates of surgery and adjuvant therapy for breast cancer vary widely between breast units. ...
Background: Primary endocrine therapy (PET) is a recognised alternative to surgery followed by endoc...
Background: Primary endocrine therapy (PET) is a recognised alternative to surgery followed by endoc...
Objective Primary Endocrine Therapy (PET) is a good alternative to surgery for breast cancer in olde...
Objective Primary Endocrine Therapy (PET) is a good alternative to surgery for breast cancer in old...
Objective: Primary endocrine therapy (PET) is an alternative to surgery for oestrogen receptor pos...
Purpose: Primary endocrine therapy (PET) is the treatment of primary, operable breast cancer with d...
Objectives: To establish older women's (≥75 years) information preferences regarding two breast canc...
Objectives: To establish older women's (≥75 years) information preferences regarding two breast canc...
Background: Around one-third of breast cancers diagnosed every year in the UK are in women aged ≥70 ...
Primary endocrine therapy (PET) as an alternative to surgery is widely used in the UK for the treatm...
Objective Primary endocrine therapy (PET) is an alternative to surgery for oestrogen receptor posit...
Kate J Lifford,1 Adrian Edwards,1 Maria Burton,2 Helena Harder,3 Fiona Armitage,4 Jenna L Morgan,4 L...
BACKGROUND: Decisions about adjuvant chemotherapy in older women with early stage breast cancer (EBC...
BackgroundRates of surgery and adjuvant therapy for breast cancer vary widely between breast units. ...